IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Travere Therapeutics Inc

CUSIP: 89422GAA5 | TRACE | 84 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Citigroup Inc53,000
0.0% of portfolio›$101.3K
Truist Financial Corp41,000
0.0% of portfolio›$87.0K
StyleTurnoverLocationFiled
Citigroup Inc
53,000$101.3K0.0%CoreMediumNew York, NY2026-11-04
Truist Financial Corp
41,000$87.0K0.0%CoreLowCharlotte, NC2026-10-30